×ðÁú¿­Ê±

EN
EN
  • ÓªÒµ×Éѯ

    Öйú£º

    Email: marketing@medicilon.com.cn

    ÓªÒµ×ÉѯרÏߣº400-780-8018

    £¨½öÏÞЧÀÍ×Éѯ£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©

    ´¨É³×ܲ¿µç»°: +86 (21) 5859-1500

    ÍâÑó£º

    +1(781)535-1428(U.S.)

    0044 7790 816 954 (Europe)

    Email:marketing@medicilon.com

ÔÚÏßÁôÑÔ¡Á
µã»÷Çл»
Customer Center
¿Í»§ÖÐÐÄ

ÖÎÁƸßѪѹ£¬ÔÿµÒ©ÒµsiRNAÐÂÒ©»ñÅúÁÙ´² | 1·ÖÖÓÒ©ÎÅËÙÀÀ

2025-07-18
|
»á¼ûÁ¿£º

19.jpgÒ½ÏßÒ©ÎÅ

1. 7ÔÂ17ÈÕ£¬ÔÿµÒ©ÒµÐû²¼£¬YKYY029×¢ÉäÒº»ñµÃÁÙ´²ÊÔÑéĬʾÔÊÐí£¬Ä⿪·¢ÖÎÁƸßѪѹ¡£ÕâÊÇÔÿµÒ©Òµ×Ó¹«Ë¾Ôÿµ¿Æ´´ºÍº¼ÖÝÌìÁú×ÔÖ÷¿ª·¢µÄ°ÐÏòAGT»ùÒòµÄС×ÌÈźËÌǺËËᣨsiRNA£©Ò©Î¾ßÓÐȫеÄÐòÁС£

2. 7ÔÂ18ÈÕ£¬Õ÷ÏéÒ½Ò©Ðû²¼×ÔÖ÷Ñз¢µÄÐÂÐÍPAÒÖÖÆ¼Á¿¹Á÷¸ÐÐÂÒ©ÂêÎøÂåɳΤÕýʽ»ñµÃÖйú¹ú¼ÒÒ©Æ·¼àÊÓÖÎÀí¾Ö£¨NMPA£©Åú×¼ÉÏÊУ¬ÓÃÓÚÖÎÁƳÉÈË´¿´âÐÔÁ÷¸Ð¡£ÂêÎøÂåɳΤÊÇÐÂÒ»´ú¾ÛºÏøËáÐÔÂѰף¨PA£©ºËËáÄÚÇÐøÒÖÖÆ¼Á£¬¾ßÓйãÆ×¿¹Á÷¸Ð²¡¶¾µÄÌØÕ÷¡£

3. 7ÔÂ18ÈÕ£¬Ç¿Éú£¨Johnson & Johnson£©Ðû²¼£¬ÃÀ¹úFDAÒÑÊÚÓèÆäÁ¢Òì°òë×ÄÚÒ©ÎïÊÍ·ÅϵͳTAR-200ÐÂÒ©ÉêÇ루NDA£©ÓÅÏÈÉóÆÀ×ʸñ£¬ÓÃÓÚÖÎÁƶԿ¨½éÃ磨BCG£©ÎÞÓ¦´ðµÄ¸ßΣ·Ç¼¡²ã½þÈóÐÔ°òë×°©£¨HR-NMIBC£©°éԭλÁö»¼Õß¡£TAR-200ÊÇÖ¼ÔÚΪ°òë×°©ÖÎÁÆÌṩһÁ¬¾Ö²¿Ò©ÎïµÝË͵ÄÊ׿î°òë×ÄÚÒ©ÎïÊÍ·Åϵͳ£¨iDRS£©¡£

4. ¿ËÈÕ£¬°Ý¶ú£¨Bayer£©Ðû²¼£¬Ó¢¹úÒ©Æ·ºÍ¿µ½¡²úÆ·ÖÎÀí¾Ö£¨MHRA£©ÒÑÅú×¼Lynkuet£¨elinzanetant£©ÓÃÓÚÖÎÁÆÓë¾ø¾­Ïà¹ØµÄÖÐÖØ¶ÈѪ¹ÜÊæËõÖ¢×´¡£LynkuetÊÇÊ׿î»ñÅúµÄË«ÖØÉñ¾­¼¤ëÄ£¨NK£©°ÐÏòÁÆ·¨¡£¸ÃÁÆ·¨µÄÉÏÊÐÉêÇëÒ²ÕýÔÚ½ÓÊÜÃÀ¹ú¡¢Å·Ã˵Äî¿Ïµµ¥Î»ÉóÆÀ¡£

ͶÈÚÒ©ÊÂ

1. ¿ËÈÕ£¬À´¶÷ÉúÎLion TCR£©ÓëÖÐйú¼ÊÁªºÏÑо¿Ôº£¨CSIRI£©ÕýʽǩÊðÕ½ÂÔÏàÖúЭÒé¡£ÕâÒ»ÏàÖú½«ÕûºÏË«·½ÔÚÉúÎïÒ½ÁÆÑз¢¡¢Ð§¹ûת»¯¼°¹ú¼Ê×ÊÔ´Áª¶¯µÄÓÅÊÆ£¬ÅäºÏÍÆ¶¯Ï¸°ûÖÎÁÆ¡¢mRNAºÍºËËáÊÖÒÕµÈÇ°ÑØÁìÓòµÄÁ¢ÒìÍ»ÆÆ£¬¹¹½¨ ¡°²úѧÑÐÓá± ЭͬÁ¢ÒìÉú̬£¬ÎªÖÐÐÂÁ½¹ú¼°ÔÁ¸Û°Ä´óÍåÇøµÄÉúÎïÒ½Áƹ¤ÒµÉú³¤×¢ÈëÇ¿¾¢¶¯Á¦¡£

2. 7ÔÂ15ÈÕ£¬¿µÕÜÒ©ÒµÕýʽÔÚÐÂ¼ÓÆÂ֤ȯÉúÒâËùÍê³ÉµÚ¶þÉÏÊУ¬´Ë´ÎÉÏÊнÓÄÉÏÈÈÝ·½·¨£¬²»Éæ¼°Ôö·¢Ð¹É£¬¹É·ÝÈÔ¼ÌÐøÓÚÏã¸ÛÁªºÏÉúÒâËùÓÐÏÞ¹«Ë¾×÷Ö÷ÒªÉÏÊм°ÉúÒâ ¡£Í¨¹ýÔÚÐÂ¼ÓÆÂÉÏÊУ¬¿µÕÜÒ©ÒµÆÚÍûÎüÒýרעÑÇ̫Ͷ×ʵĻù½ð¼°¶«ÄÏÑDZ¾ÍÁ×ÊÔ´£¬ÓÅ»¯×ÔÉí¹É¶«½á¹¹£¬Í¬Ê±Íƶ¯ÆäÔÚ¶«ÄÏÑǼ°Öж«µÄÓªÒµÉú³¤¡£

¿Æ¼¼Ò©ÑÐ

1. ¿ËÈÕ£¬°Ä´óÀûÑDZ˵éqÂó¿¨ÀÕÄ·°©Ö¢ÖÐÐÄPaul A. Beavis¡¢Phillip K. Darcy¡¢Amanda X. Y. ChenºÍKah Min YapÁªºÏÔÚNatureÆÚ¿¯ÉϽÒÏþÁËÎÄÕÂRewiring endogenous genes in CAR T cells for tumour-restricted payload delivery£¬±¾Ñо¿¿ª·¢ÁËÒ»ÖÖÁ¢ÒìµÄCRISPR»ùÒò±à¼­Õ½ÂÔ£¬Í¨¹ý½«ÖÎÁÆÐÔϸ°ûÒò×Ó£¨ÈçIL-12£©¾«×¼²åÈëCAR-Tϸ°ûµÄÄÚÔ´ÐÔ»ùÒò£¨NR4A2/RGS16£©Î»µã£¬Ê¹ÓÃÕâЩ»ùÒòµÄÖ×Áö΢ÇéÐÎÌØÒìÐÔÆô¶¯×ÓʵÏÖϸ°ûÒò×ӵľ«×¼¶¨Î»±í´ï£¬ÔÚÏÔÖøÔöÇ¿¿¹Ö×ÁöÁÆÐ§µÄͬʱ×èÖ¹ÁËÈ«Éí¶¾ÐÔ£¬ÎªÊµÌåÁöµÄCAR-TÖÎÁÆÌṩÁËÍ»ÆÆÐÔ½â¾ö¼Æ»®¡£

[1]Chen, A.X.Y., Yap, K.M., Kim, J.S. et al. Rewiring endogenous genes in CAR T cells for tumour-restricted payload delivery. Nature (2025). https://doi.org/10.1038/s41586-025-09212-7

Ïà¹ØÐÂÎÅ
¡Á
ËÑË÷ÑéÖ¤
µã»÷Çл»
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿